Reuters: Global Markets: Biogen bets more on Isis technology for neurological drugs

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Marketing Mobile Apps This online course focuses on marketing efforts that will increase your app's exposure and establish a mobile app marketing plan. Enroll today for $99. From our sponsors

Biogen bets more on Isis technology for neurological drugs Sep 9th 2013, 12:21 The company's name is displayed on a billboard near the headquarters of Biogen Idec Inc. in Cambridge, Massachusetts June 18, 2008. Credit: Reuters/Brian Snyder

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions